Abstract
C23H25NO3, monoclinic, P21 (no. 4), a = 15.2433(7) Å, b = 5.8687(3) Å, c = 22.3558(11) Å, β = 105.461(2)°, V = 1927.54(16) Å3, Z = 4, R gt(F) = 0.0413, wR ref(F 2) = 0.1055, T = 100(2) K.
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
Crystal: | Colourless block |
Size: | 0.12 × 0.11 × 0.10 mm |
Wavelength: | MoKα radiation (0.71073 Å) |
μ: | 0.08 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
θ max, completeness: | 27.7°, >99 % |
N(hkl)measured, N(hkl)unique, R int: | 71,927, 8918, 0.046 |
Criterion for I obs, N(hkl)gt: | I obs > 2 σ(I obs), 8051 |
N(param)refined: | 493 |
Programs: | Bruker [1], Olex2 [2], Shelx [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Atom | x | y | z | U iso*/U eq |
---|---|---|---|---|
C1 | 0.06837 (18) | 1.6084 (5) | 0.95343 (12) | 0.0324 (6) |
H1A | 0.033347 | 1.621226 | 0.909913 | 0.049* |
H1B | 0.113271 | 1.731650 | 0.963496 | 0.049* |
H1C | 0.027089 | 1.619531 | 0.980240 | 0.049* |
C2 | 0.11720 (17) | 1.3793 (5) | 0.96378 (11) | 0.0276 (6) |
H2A | 0.151955 | 1.367209 | 1.007907 | 0.033* |
H2B | 0.071278 | 1.255867 | 0.955131 | 0.033* |
C3 | 0.18175 (15) | 1.3453 (4) | 0.92336 (10) | 0.0215 (5) |
C4 | 0.25403 (16) | 1.4931 (4) | 0.92606 (10) | 0.0225 (5) |
H4 | 0.264981 | 1.616978 | 0.954451 | 0.027* |
C5 | 0.31011 (16) | 1.4588 (4) | 0.88706 (10) | 0.0208 (5) |
H5 | 0.360209 | 1.557485 | 0.889012 | 0.025* |
C6 | 0.29215 (15) | 1.2781 (4) | 0.84498 (10) | 0.0200 (5) |
C8 | 0.17068 (16) | 1.1671 (5) | 0.88081 (11) | 0.0244 (5) |
H8 | 0.122346 | 1.062963 | 0.879048 | 0.029* |
C9 | 0.34953 (17) | 1.2356 (4) | 0.80041 (11) | 0.0229 (5) |
H9A | 0.310253 | 1.235428 | 0.757287 | 0.027* |
H9B | 0.394876 | 1.359263 | 0.804209 | 0.027* |
C10 | 0.39778 (16) | 1.0095 (4) | 0.81446 (10) | 0.0213 (5) |
H10A | 0.435649 | 1.006307 | 0.857962 | 0.026* |
H10B | 0.352880 | 0.884018 | 0.808619 | 0.026* |
C11 | 0.50806 (15) | 0.7960 (4) | 0.78198 (10) | 0.0193 (5) |
C12 | 0.56224 (15) | 0.7744 (4) | 0.73406 (10) | 0.0193 (5) |
H12 | 0.590414 | 0.925765 | 0.730292 | 0.023* |
C13 | 0.63886 (16) | 0.5999 (5) | 0.75534 (11) | 0.0274 (5) |
H13A | 0.681518 | 0.652910 | 0.793793 | 0.041* |
H13B | 0.671098 | 0.582179 | 0.723104 | 0.041* |
H13C | 0.613038 | 0.453038 | 0.762742 | 0.041* |
C14 | 0.44808 (15) | 0.5073 (4) | 0.66278 (10) | 0.0182 (4) |
H14 | 0.452165 | 0.410014 | 0.697370 | 0.022* |
C15 | 0.49834 (14) | 0.7139 (4) | 0.67096 (10) | 0.0167 (4) |
C16 | 0.49061 (14) | 0.8549 (4) | 0.62069 (10) | 0.0159 (4) |
H16 | 0.522608 | 0.995595 | 0.626147 | 0.019* |
C17 | 0.43597 (14) | 0.7951 (4) | 0.56094 (10) | 0.0145 (4) |
C18 | 0.38717 (14) | 0.5859 (4) | 0.55250(9) | 0.0142 (4) |
C19 | 0.39357 (15) | 0.4460 (4) | 0.60554 (10) | 0.0172 (4) |
H19 | 0.359700 | 0.308296 | 0.601310 | 0.021* |
C20 | 0.43177 (14) | 0.9341 (4) | 0.50789 (10) | 0.0165 (4) |
H20 | 0.461538 | 1.077825 | 0.512993 | 0.020* |
C21 | 0.38556 (14) | 0.8633 (4) | 0.44995 (10) | 0.0174 (4) |
H21 | 0.385423 | 0.954999 | 0.414903 | 0.021* |
C22 | 0.33760 (14) | 0.6529 (4) | 0.44177 (10) | 0.0162 (4) |
C23 | 0.33622 (14) | 0.5186 (4) | 0.49179 (10) | 0.0160 (4) |
H23 | 0.301621 | 0.381838 | 0.486067 | 0.019* |
C24 | 0.25315 (16) | 0.3843 (4) | 0.36967 (10) | 0.0210 (5) |
H24A | 0.228742 | 0.361848 | 0.324867 | 0.032* |
H24B | 0.203353 | 0.377706 | 0.389741 | 0.032* |
H24C | 0.297506 | 0.264282 | 0.386623 | 0.032* |
C25 | 0.5923 (2) | 0.5174 (6) | 0.99068 (14) | 0.0382 (7) |
H25A | 0.593639 | 0.664498 | 0.970208 | 0.057* |
H25B | 0.647422 | 0.500637 | 1.024981 | 0.057* |
H25C | 0.538591 | 0.510260 | 1.006852 | 0.057* |
C26 | 0.58800 (15) | 0.3270 (5) | 0.94433 (11) | 0.0236 (5) |
H26A | 0.534892 | 0.353873 | 0.908352 | 0.028* |
H26B | 0.577264 | 0.181905 | 0.963850 | 0.028* |
C27 | 0.67177 (15) | 0.2991 (4) | 0.92058 (10) | 0.0180 (5) |
C28 | 0.73496 (15) | 0.4704 (4) | 0.92229 (11) | 0.0214 (5) |
H28 | 0.727781 | 0.614643 | 0.939669 | 0.026* |
C29 | 0.80912 (15) | 0.4299 (4) | 0.89837 (11) | 0.0202 (4) |
H29 | 0.851670 | 0.547687 | 0.897868 | 0.024* |
C30 | 0.81998 (15) | 0.2148 (4) | 0.87526 (10) | 0.0194 (5) |
C32 | 0.68804 (16) | 0.0924 (4) | 0.89557 (11) | 0.0236 (5) |
H32 | 0.644793 | −0.025816 | 0.893681 | 0.028* |
C33 | 0.89934 (16) | 0.1575 (4) | 0.84941 (11) | 0.0228 (5) |
H33A | 0.940216 | 0.290927 | 0.853307 | 0.027* |
H33B | 0.934565 | 0.029625 | 0.873092 | 0.027* |
C34 | 0.86379 (16) | 0.0918 (5) | 0.78196 (11) | 0.0247 (5) |
H34A | 0.822062 | −0.039721 | 0.778441 | 0.030* |
H34B | 0.828725 | 0.220623 | 0.758657 | 0.030* |
C35 | 0.96799 (16) | −0.1830 (4) | 0.76251 (10) | 0.0207 (5) |
C36 | 1.03660 (15) | −0.2296 (4) | 0.72529 (10) | 0.0189 (5) |
H36 | 1.070573 | −0.085533 | 0.722920 | 0.023* |
C37 | 1.10484 (17) | −0.4122 (5) | 0.75617 (11) | 0.0301 (6) |
H37A | 1.140584 | −0.357599 | 0.796789 | 0.045* |
H37B | 1.145629 | −0.445192 | 0.729996 | 0.045* |
H37C | 1.072167 | −0.551234 | 0.761573 | 0.045* |
C38 | 0.93283 (15) | −0.5026 (4) | 0.64924 (10) | 0.0177 (4) |
H38 | 0.934799 | −0.601855 | 0.683141 | 0.021* |
C39 | 0.98212 (14) | −0.2945 (4) | 0.65986 (10) | 0.0158 (4) |
C40 | 0.97825 (14) | −0.1512 (4) | 0.61065 (10) | 0.0150 (4) |
H40 | 1.010390 | −0.010796 | 0.617538 | 0.018* |
C41 | 0.92697 (14) | −0.2093 (4) | 0.54953 (10) | 0.0137 (4) |
C42 | 0.87882 (14) | −0.4190 (4) | 0.53896 (9) | 0.0142 (4) |
C43 | 0.88241(14) | −0.5627 (4) | 0.59088 (10) | 0.0162 (4) |
H43 | 0.849478 | −0.702028 | 0.585036 | 0.019* |
C44 | 0.92538 (14) | −0.0663 (4) | 0.49793 (10) | 0.0158 (4) |
H44 | 0.955210 | 0.077218 | 0.504460 | 0.019* |
C45 | 0.88137 (15) | −0.1333 (4) | 0.43903 (10) | 0.0167 (4) |
H45 | 0.882711 | −0.038329 | 0.404871 | 0.020* |
C46 | 0.83362 (14) | −0.3437 (4) | 0.42847 (10) | 0.0159 (4) |
C47 | 0.83042 (14) | −0.4827 (4) | 0.47734 (10) | 0.0156 (4) |
H47 | 0.796267 | −0.620148 | 0.470178 | 0.019* |
C48 | 0.74854 (17) | −0.6034 (4) | 0.35303 (11) | 0.0237 (5) |
H48A | 0.729016 | −0.624616 | 0.307933 | 0.036* |
H48B | 0.695207 | −0.605776 | 0.369657 | 0.036* |
H48C | 0.790142 | −0.726629 | 0.371898 | 0.036* |
N1 | 0.22323 (14) | 1.1317 (4) | 0.84210 (9) | 0.0242 (4) |
N2 | 0.75986 (15) | 0.0460 (4) | 0.87386 (10) | 0.0263 (5) |
O1 | 0.45483 (11) | 0.9825 (3) | 0.77199 (7) | 0.0216 (4) |
O2 | 0.51064 (12) | 0.6639 (3) | 0.82377 (8) | 0.0269 (4) |
O3 | 0.29660 (10) | 0.6014 (3) | 0.38101 (7) | 0.0194 (3) |
O4 | 0.93732 (11) | 0.0324 (3) | 0.75463 (7) | 0.0225 (4) |
O5 | 0.94111 (14) | −0.3212 (3) | 0.79315 (8) | 0.0343 (4) |
O6 | 0.79413 (10) | −0.3892 (3) | 0.36703 (7) | 0.0204 (3) |
1 Source of materials
Naproxen acylchloride was synthesized according to the literature method [4]. 5-Ethyl-2-pyridineethanol (0.01 mol, 1.51 g) and 4-(dimethylamino)-pyridin (DMAP, 0.0015 mol, 0.18 g) were dissolved in dry tetrahydrofuran (20 mL) and triethylamine (0.015 mol, 2 mL). The solution of naproxen acylchloride in dry tetrahydrofuran was dropwise added at 0 °C. The reaction mixture was stirred for 2 h at room temperature. The reaction mixture was filtrated to remove the solid and the filtrate was concentrated under vacuum to remove the solvent. The residue was dissolved in dichloromethane, successively washed with 5 % NaOH solution and water to pH = 7, and dried with anhydrous Na2SO4. The solution was filtrated, and concentrated under vacuum to obtain crude product. The crude product was purified by recrystallization in ethanol. The single crystals were obtained from tetrahydrofuran solution.
2 Experimental details
H atoms were set to calculated positions. The U iso values were set to be 1.5U eq of the carrier atom for methyl H atoms and 1.2U eq for the remaining H atoms.
3 Comment
Naproxen is one of the strongest non-steroidal anti-inflammatory drugs (NSAIDs), inhibits the cyclooxygenase (COX) enzymes both COX-1 and COX-2. Inhibits both COX-1 and COX-2 which are the enzymes of cyclooxygenase (COX). Naproxen displays analgesic, anti-inflammatory, and antipyretic activity. In addition, the researchers reported anticancer l activities of naproxen derivatives [5]. In cure of advancing prostate cancer, naproxen was discovered to be reliable and effective with early repetitive disease in a phase II clinical trial [6]. And naproxen and its derivatives have been shown to be effective as well as other NSAIDs to prevent urinary bladder cancer. By inducing apoptosis and cell cycle arrest toward bladder cancer cells, naproxen displayed anticancer influences. Naproxen inhibited protein kinase B (AKT) phosphorylation and induced apoptosis in rat urinary bladder cancers [7]. In order to achieve high efficiency, low toxicity and cost anti-tumor drugs, we chose naproxen as a core compound and modify its structures.
The compound contains two twist 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate molecules in the asymmetric unit (see Figure). The title compound contained one pyridine ring and one naphthyl moiety. The C=O double bond lengths in the independent molecule are 1.207(3) Å (C11=O2) and 1.202(3) Å (C35=O5), respectively, exhibiting the double bond character. The dihedral angles of ring 1 (C3–C4–C5–C6–N1–C8) and ring 2 (C14–C15–C16–C17–C18–C19), ring 1 (C3–C4–C5–C6–N1–C8) and ring 3 (C17–C18–C23–C22–C21–C20), ring 2 (C14–C15–C16–C17–C18–C19) and ring 3 (C17–C18–C23–C22–C21–C20), ring 4 (C27–C28–C29–C30–N2–C32) and ring 5 (C38–C39–C40–C41–C42–C43), ring 4 (C27–C28–C29–C30–N2–C32) and ring 6 (C42–C41–C44–C45–C46–C47), ring 5 (C38–C39–C40–C41–C42–C43) and ring 6 (C42–C41–C44–C45–C46–C47) are 52.2°, 55.0°, 4.6°, 75.6°, 72.1°, 3.5°, respectively. The other bond distances and angles are in their normal ranges according to the previously reported compounds [8, 9].
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: None declared.
-
Conflict of interest statement: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. Saint and Sadabs; Bruker AXS Inc.: Madison, Wisconsin, USA, 2000.Suche in Google Scholar
2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar
3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar
4. Huang, Z., Velázquez, C. A., Abdellatif, K. R. A., Chowdhury, M. A., Reisz, J. A., DuMond, J. F., King, S. B., Knaus, E. E. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies. J. Med. Chem. 2011, 54, 1356–1364; https://doi.org/10.1021/jm101403g.Suche in Google Scholar PubMed
5. Han, M. I., Kucukguzel, S. G. Anticancer and antimicrobial activities of naproxen and naproxen derivatives. Mini Rev. Med. Chem. 2020, 20, 1300–1310; https://doi.org/10.2174/1389557520666200505124922.Suche in Google Scholar PubMed
6. Srinivas, S., Feldman, D. A phase II trial of calcitriol and naproxen in recurrent porstate cancer. Anticancer Res. 2009, 29, 3605–3610.Suche in Google Scholar
7. Kim, M. S., Kim, J. E., Lim, D. Y., Huang, Z., Chen, H., Langfald, A., Lubet, R. A., Grubbs, C. J., Dong, Z., Bode, A. M. Naproxen induces cell cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting P13-K. Canc. Prev. Res. 2014, 7, 236–245; https://doi.org/10.1158/1940-6207.capr-13-0288.Suche in Google Scholar PubMed PubMed Central
8. Wang, L. L., Xue, D. D. Crystal structure of 3-phenylpropyl 2-(6-methoxynaphthalen-2-yl)propanpate, C23H24O3. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 517–519; https://doi.org/10.1515/ncrs-2022-0114.Suche in Google Scholar
9. Liang, D., Yang, X. H., Sun, W., Wang, W. N., Yang, J. Z., Liu, Y. Y., Wang, G. S. Synthesis, crystal structure and biological activities of naproxen-eugenol ester progrug. Chem. Res. Chinese Univ. 2013, 29, 245–248; https://doi.org/10.1007/s40242-013-2266-9.Suche in Google Scholar
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
- Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
- The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
- Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
- The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
- The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
- The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
- Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
- Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
- The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
- The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
- Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
- Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
- Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
- Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
- Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
- Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
- Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
- Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
- Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
- The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
- The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
- Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
- Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
- The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
- Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
- The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
- The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
- Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
- The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
- The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
- The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
- Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
- The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
- The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
- The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
- Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
- The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
- Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
- Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
- The crystal structure of unsymmetrical BOPHY C26H27BN4
- The crystal structure of Tb3B5O11(OH)2
- The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
- Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
- The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
- Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
- The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
- Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
- Single-crystal structure determination of Tm3B12O19(OH)7
- Crystal structure determination of NdB3.6O7
- The crystal structure of NdB6O8(OH)5·H3BO3
- Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
- Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
- Crystal structure of Ba6Cd12Mn4SiF48
- Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
- The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
- Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
- The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
- Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
- The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
- Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
- Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
- The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
- Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
- Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
- The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
- The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
- Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
- The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
- Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
- The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
- The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
- The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
- Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
- Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
- The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
- The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
- Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
- Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
- Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
- Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
- Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
- Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
- Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
- Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
- Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
- The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
- The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
- Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
- Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
- The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
- Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
- The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
- The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
- Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
- The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
- The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
- The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
- Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
- The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
- The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
- The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
- Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
- The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
- Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
- Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
- The crystal structure of unsymmetrical BOPHY C26H27BN4
- The crystal structure of Tb3B5O11(OH)2
- The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
- Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
- The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
- Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
- The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
- Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
- Single-crystal structure determination of Tm3B12O19(OH)7
- Crystal structure determination of NdB3.6O7
- The crystal structure of NdB6O8(OH)5·H3BO3
- Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
- Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
- Crystal structure of Ba6Cd12Mn4SiF48
- Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
- The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
- Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
- The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
- Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
- The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
- Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
- Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
- The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
- Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
- Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
- The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
- The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3